| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |